New Materials Series B Investors & VC Firms
280 firms in this list, with a median first check of $540K. 13 of them lead rounds. Generated from verified public data and updated continuously.
Kumpulan Modal Perdana
Petaling JayaSeed–Late Stage
3 people
Murray Hill Group
New YorkSeed–Late Stage
3 people
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
Overlap Holdings
HicksvilleSeed–Series B
3 people
Q Venture Partners
Seed–Series B
3 people
TD Growth Capital Co. Ltd.
ShanghaiSeed–Series B
3 people
Tsing Capital
BeijingSeries A–Late Stage
3 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
3 people
ALLEGIS CAPITAL
Palo AltoSeed–Series B$10M
2 people
Alibaba Entrepreneurs Fund
Hong KongSeed–Late Stage
2 people
Chevron Technology Ventures
HoustonSeries A–Late Stage
1 person
BCP Ventures
DoverSeed–Series B
2 people
BSK Investment
SeoulSeed–Late Stage
2 people
Carrier Ventures
Palm Beach GardensSeries A–Series B
2 people
Checkmate Capital Group LLC
PasadenaSeed–Late Stage
2 people
Comway Capital Ltd.
ShanghaiSeed–Series B
2 people
Earthrise Capital
New YorkSeries A–Late Stage
2 people
Elron Ventures
Tel AvivSeed–Series B
2 people
IDATEN Ventures
TokyoSeed–Series B
2 people
Kama Flow
MoscowSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Pearl Abyss Capital
SeoulSeed–Late Stage
2 people
RenewableTech Ventures
Salt Lake CitySeries A–Series B
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Related lists
Series B Investors & VC Firms (2615)Series B Investors & VC Firms in United States (1005)SaaS Series B Investors & VC Firms (750)Enterprise Software Series B Investors & VC Firms (731)New Materials Investors & VC Firms (652)Healthtech Series B Investors & VC Firms (596)New Materials Series A Investors & VC Firms (590)New Materials Seed Investors & VC Firms (560)Fintech Series B Investors & VC Firms (550)Biotech Series B Investors & VC Firms (526)
Data sourced from public filings and firms' own websites — see our methodology.